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A verotoxin-producing Escherichia coli serotype O111:NM strain (strain 10049; verotoxin 1 positive)
persistently infected experimentally inoculated gnotobiotic pigs, causing attaching-effacing intestinal lesions
and chronic diarrhea. Experiments were performed to determine whether persistent infection might be
associated with immunocompromise of the host by this organism. Pigs inoculated with this strain had a
significant reduction in peripheral blood lymphocytes and lower antibody titers to sheep erythrocytes compared
with control pigs. Compared with pigs given a verotoxin-negative pathogenic strain of the same serotype
(O111:NM, strain 2430), pigs inoculated with the verotoxin-positive strain had lower peripheral lymphocyte
counts and proliferative responses to concanavalin A, phytohemagglutinin, and pokeweed mitogens. The
results of this study suggest that strain 10049 has an immunocompromising effect on gnotobiotic pigs.
Certain strains ofEscherichia coli frequently referred to as
enterohemorrhagic E. coli (EHEC) (22) produce verotoxin 1
(VT1) and/or verotoxin 2 (VT2) (Shiga-like toxin I and/or II)
and attach to and efface the microvilli from intestinal epithe-
lium. These organisms have been incriminated as a cause of
hemorrhagic or nonhemorrhagic colitis in humans and other
animals (9, 17, 18). In humans, they may also cause hemo-
lytic uremic syndrome (8) and thrombotic thrombocytopenic
purpura (26). Verotoxins are believed to be virulence factors
in these syndromes, but their role in disease remains un-
clear. When applied to HeLa or Vero cells, the toxins are
cytolytic (21, 27), and VT1 administered parenterally to
experimental animals caused necrosis of the endothelial and
muscular layers of blood vessels (7a, 31). However, in one
experimental model, the toxins did not appear essential for
the generation of diarrhea in these animals (39).
Gnotobiotic pigs are very susceptible to experimental
infection by EHEC and have been used by several investi-
gators as a model for studying the pathogenesis of disease
caused by these organisms (9, 12, 38, 40, 41). When gnoto-
biotic pigs are inoculated with verotoxigenic E. coli (VTEC),
they develop nonbloody diarrhea and, with certain strains,
neurologic disease also occurs (10). A description of the
pathogenesis of acute illness has been the focus of the
previously reported experimental challenge studies. In those
studies, animals were observed for 5 days or less after
inoculation. In contrast, we maintained gnotobiotic pigs for
3 to 4 weeks following inoculation with a serotype O111:NM
VTEC strain, and these animals remained diarrheic through-
out. Examination of diarrheic pigs revealed histologic evi-
dence of chronic typhlocolitis and persistent infection of
intestinal epithelium by the challenge organism.
Chronic infection caused by E. coli serotype O111:NM
has also been previously reported (1, 7, 19, 33, 34). Persis-
tent diarrhea is a recognized clinical expression of entero-
* Corresponding author.
t Journal series no. 2666 and 10013 of the Agricultural Experi-
ment Station, South Dakota State University, and the Agricultural
Research Division, University of Nebraska at Lincoln, respectively.
pathogenic E. coli (EPEC) infection in humans (23). Clinical
cases involving EHEC organisms in which patients had
diarrhea that persisted up to 2 weeks (19) and was of a
duration similar to that of the EPEC cases have been
reported (7, 33). However, the potential for various EPEC
and EHEC strains to cause diarrhea for this length of time
has not been investigated in the gnotobiotic pig model. We
have identified an EHEC strain which has the capacity to
cause chronic infection in gnotobiotic pigs and is of a
serotype (O111:NM) associated with persistent diarrhea.
The purpose of our study was to determine whether the
chronic infection and colitis observed in gnotobiotic pigs
inoculated with VTEC (O111:NM) might be associated with
an immunocompromised condition.
MATERIALS AND METHODS
Animals. Gnotobiotic pigs were obtained by closed hyste-
rotomy and maintained in rigid tub isolators similar to those
previously described (25).
Bacterial strains. Three E. coli strains, 10049, 2430, and
G58-1, were used to inoculate gnotobiotic pigs. Strain 10049
(serotype O111:NM) was isolated from a calf with diarrhea.
It did not produce pilus antigen K88, K99, or 987P or
heat-labile or heat-stabile enterotoxins. It was noninvasive
in the Sereny test and was probe positive for the EHEC
plasmid (as determined by the pCVD 419 probe) (24) and
VT1, but not VT2. This information was provided by Brad-
ford A. Kay (Center for Vaccine Development, University
of Maryland, Baltimore, Md.). A high level of VT1 is
produced by this organism as measured in the HeLa cell
assay described by Alison D. O'Brien (Uniformed Services
University of the Health Sciences, Bethesda, Md.). This
strain was also negative for adherence to HEp-2 cells as
reported by Carol Maddox (University of Missouri, Colum-
bia, Mo.) and to Int-407 cells.
E. coli 2430 (serotype O111:NM), a human, non-vero-
toxin-producing isolate was provided by Nancy Stockbrine
(Centers for Disease Control, Atlanta, Ga.). It was probe
negative for VT1, VT2, and the EHEC plasmid but was
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probe positive for the EPEC adherence factor, as reported
by Carol Maddox.
Strain G58-1 (serotype 0101:K28:NM) (9), a nonpatho-
genic porcine isolate, was provided by Werner K. Maas
(New York University, New York, N.Y.). It did not adhere
to HEp-2 cells and was negative by gene probe for VT1,
VT2, and the EHEC plasmid. All of the bacterial strains
were maintained frozen on porous beads (Protect; Pro-Lab,
Inc., Round Rock, Tex.) at -70°C, until use.
Bacterial inoculation. Bacterial strains were cultured on
5% sheep blood (heart infusion) agar (Difco, Detroit, Mich.)
for 18 to 24 h, transferred to tryptic soy broth (Difco), and
cultivated overnight at 37°C (to approximately 109 CFU/ml).
At 24 h of age, pigs were given orally 3 ml of the culture
suspension or 3 ml of uninoculated broth. Multiple litters of
pigs were used in most experiments, and pigs within litters
were divided between principal and control groups.
Blood collection. Once weekly, 10 ml of peripheral blood
from the anterior vena cava was collected in heparinized
tubes for lymphocyte counts and mitogenesis assays. Serum
for the analysis of anti-sheep erythrocyte (SRBC) titers was
collected when pigs were 4 weeks of age.
Clinical evaluation and postmortem examination. Pigs were
evaluated three times daily for anorexia, diarrhea, or leth-
argy. Pigs were euthanized at 3 to 4 weeks of age. Necropsy
examination included evaluation for gross lesions and col-
lection of tissue samples from the stomach, duodenum,
jejunum, ileum, cecum, spiral colon (two locations), rectum,
liver, lung, spleen, and thymus for histologic evaluation.
Tissue samples for histologic examination were fixed in 10%
neutral buffered formalin, processed by routine methods,
paraffin embedded, sectioned into 6-,um pieces, and stained
with hematoxylin and eosin. Fecal samples were collected
from the colon for bacteriologic culture to confirm challenge
inoculation and to test for bacterial contamination. Bacterial
isolates were evaluated by a cytotoxicity assay for the
presence or absence of verotoxin (11).
Total lymphocyte counts. Total peripheral leukocyte
counts were determined with an automated cell counter
(model MHR; Coulter Electronics, Inc., Hialeah, Fla.), and
differential counts were determined microscopically on
Wright-stained blood smears (Hema-Quik; Biochemical Sci-
ences, Inc. Bridgeport, N.J.). The total lymphocyte count
was calculated by multiplying the percentage of lymphocytes
by the total leukocyte count.
Immunization protocol. To determine their ability to
mount an immune response, the pigs were injected with 1 ml
of a 10% solution of SRBCs in sterile phosphate-buffered
saline (PBS; pH 7.4). The injection was given subcutane-
ously at 3 days postinoculation and again 2 weeks later.
Anti-SRBC titers. Serum was analyzed for antibodies to
SRBCs via a complement-mediated hemolysis test (29).
SRBCs were suspended in citrate buffer, washed twice, and
then resuspended to 1% (vol/vol) in PBS. Porcine serum was
heat inactivated for 30 min at 56°C and serially diluted in
twofold increments after heat inactivation. Fifty microliters
of a 1:10 dilution of lyophilized guinea pig complement
(GIBCO, Grand Island, N.Y.) was added to the serially
diluted porcine serum along with 0.1 ml of the 1% SRBC
solution. Two controls per serum sample, one with serum
plus SRBCs but no complement and one with complement
plus SRBCs but no serum, were included. All mixtures were
incubated at 37°C for 1 h, and the titer was determined
visually as the last serum dilution in which complete SRBC
lysis occurred.
Mitogen assays. Peripheral blood was collected in heparin
from each pig, diluted 1:5 in Ca2"-Mg2+-free PBS, layered
onto Histopaque 1077 (Sigma Chemical Co., St. Louis,
Mo.), and centrifuged at 650 x g for 25 min. Mononuclear
cells were collected from the buffer-Histopaque interface,
washed three times in PBS containing a 1:100 dilution of
preservative-free heparin, and suspended at 3 x 106 cells per
ml in RPMI-1640 medium (Sigma) with 10% fetal bovine
serum. Concanavalin A, phytohemagglutinin, pokeweed mi-
togen, and lipopolysaccharide were diluted in RPMI-1640
medium for final concentrations of 1, 1, 5, and 16 ,ug/ml,
respectively. The cell suspension was then mixed with an
equal volume of each mitogen and plated in triplicate on a
96-well microtiter plate (Corning, Corning, N.Y.). Lympho-
cytes were incubated at 37°C with concanavalin A, phyto-
hemagglutinin, and pokeweed mitogen for 48 h or with
lipopolysaccharide for 72 h. Tritiated thymidine (ICN, Irv-
ine, Calif.) at 0.2 ,uCi per well was added to each well 4 h
prior to the end of incubation. Incorporation of [3H]thymi-
dine was determined in a scintillation counter (Beckman,
Arlington Heights, Ill.) after cells were harvested on filter
paper (Brandel, Gaithersburg, Md.). Each filter disk was
placed in 3 ml of scintillation fluid (Cyto-Scint; ICN) in 7-ml
vials. Specific incorporation, reported for our study, was
determined by the average counts per minute (cpm) for the
sample (equal volume of each mitogen mixed with equal
volume of lymphocytes) minus the average counts per
minute for the control sample (equal volumes of RPMI-1640
medium mixed with equal volumes of lymphocytes).
Statistical analysis. A maximum-likelihood analysis of vari-
ance test (35) was used as a nonparametric statistical mea-
sure when infected and control samples were compared.
Statistical significance is reported throughout the text and in
the figures at the P c 0.05 level of confidence. All values
reported in the text and figures are means + the standard
errors of the means (SEM).
RESULTS
Clinical signs and postmortem examination. Surviving pigs
inoculated with strain 10049 had persistent diarrhea and
anorexia associated with chronic typhlocolitis. Twenty-three
(85%) of 27 strain 10049-inoculated pigs had diarrhea which
persisted until the pigs were euthanized at 3 to 4 weeks
postinoculation. The other four pigs died 5 days after inoc-
ulation, before the onset of diarrhea. Of the strain 2430-
inoculated pigs, seven (78%) of nine developed transient
diarrhea, and three were anorexic for only a couple of days.
Five (38%) of 13 of the uninoculated control pigs developed
transient diarrhea, but none exhibited depression or an-
orexia.
Histopathologic examination of the large intestines of nine
pigs inoculated with strain 10049 revealed attaching-effacing
bacterial colonization of the luminal and crypt epithelial
surfaces in seven (78%), loss of crypt epithelium and fibrosis
in the mucosa or submucosa in six (67%), and neutrophilic
inflammation of the mucosal surfaces, chronic inflammation
of the laminae propriae and submucosae, and loss of lym-
phoglandular complexes in seven (78%). Histologic exami-
nation of the lymphoid tissues revealed atrophy of the
periarterial lymphatic sheaths of the spleens in six (67%) of
nine pigs. Two pigs lacking attaching-effacing lesions also
did not demonstrate chronic colitis or lymphoid depletion of
the lymphoglandular complexes and periarterial lymphatic
sheaths. No histopathologic lesions were seen in pigs inoc-
ulated with strain 2430 (n = 11) or G58-1 (n = 16) or in the
uninoculated controls (n = 8). Thymic tissues of pigs in all
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FIG. 1. The absolute lymphocyte counts for uninoculated pigs
and pigs inoculated with E. coli 2430 or 10049. The number of pigs
tested were 13, 6, and 20 (week 1); 13, 6, and 15 (week 2); 11, 4, and
14 (week 3); and 3, 4, and 5 (week 4) for uninoculated controls
( E ), strain 2430-inoculated pigs (in), and strain 10049-inoculated
pigs ( M ), respectively. Significant different (P < 0.05) from results
for uninoculated controls and for strain 2430-inoculated pigs are
indicated by + and *, respectively.
treatment groups appeared normal by microscopic examina-
tion.
Loosely adherent bacteria were seen in the large intestines
of pigs inoculated with strain G58-1, 2430, or 10049 and
occasionally in those of the uninoculated controls. Results of
bacterial culture and serotyping analysis confirmed the pres-
ence of serotype O111:NM in pigs inoculated with strain
10049 or 2430 and serotype O101:NM in pigs inoculated with
strain G58-1. Verotoxin analysis indicated that isolates from
pigs inoculated with strain 10049 produced verotoxin in large
amounts (titer, >640), whereas bacteria from pigs in the
other treatment groups did not produce verotoxin. Low
numbers of Bacillus sp. contaminants were cultured for all
treatment groups. However, the majority of Bacillus spp.
have little or no pathogenic potential and are rarely associ-
ated with disease in humans or lower animals (37).
Total lymphocyte count. Changes in the distribution of
leukocytes have been associated with reduced immune com-
petence (2, 15). Therefore, peripheral blood was examined
for the total leukocyte count and the percentage of lympho-
cytes. Pigs inoculated with strain 10049 had a significantly
decreased absolute mean lymphocyte count compared with
that of uninoculated controls for weeks 1 to 4 postinocula-
tion and that of strain 2430-inoculated pigs for weeks 2 to 4
postinoculation (Fig. 1). The mean lymphocyte count for
pigs inoculated with strain 10049 at 4 weeks of age only was
significantly lower than that for pigs inoculated with strain
G58-1 (P < 0.001) (data not shown).
Anti-SRBC titers. The antibody response to a complex
antigen was determined in each treatment group via an
anti-SRBC titer. The geometric mean anti-SRBC titer for
pigs inoculated with strain 10049 was significantly lower than
that for G58-1-inoculated pigs or uninoculated controls. A
trend for a lower geometric mean titer was also observed in
pigs inoculated with strain 10049 compared with those given
strain 2430 (P = 0.07) (Fig. 2). No significant differences
were noted in antibody titers between uninoculated controls
and pigs given strain 2430 (P = 0.12). Uninoculated controls
and strain 2430- and 10049-inoculated pigs all had titers
significantly lower than those of pigs inoculated with G58-1
(Fig. 2).
Mitogen assays. Reduced functional activity of lympho-
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FIG. 2. Antibody titers to SRBCs for uninoculated pigs (n = 3)
(in) and pigs inoculated with strain G58-1 (n = 15) (i), 10049 (n
= 13) ( M ) or 2430 (n = 7) ( ) at 4 weeks postinoculation.
Significant differences (P c 0.05) from results for strain G58-1-
inoculated pigs and for uninoculated controls are indicated by + and
0, respectively.
cytes was indicated by the results of mitogen assays, which
indicated that lymphocytes from pigs inoculated with VTEC
did not have the same potential to undergo clonal expansion
as did those from control pigs or from pigs inoculated with
verotoxin-negative E. coli (Fig. 3). Concanavalin A, phyto-
hemagglutinin, and pokeweed mitogens induced lymphocyte
proliferation in pigs inoculated with strain 10049 that was
significantly lower than the proliferation in pigs given strain
2430 or uninoculated pigs throughout the 4 weeks assayed.
The mitogenic response to lipopolysaccharide for all treat-
ment groups was too low for comparisons to be made. The
capacity of B cells to undergo a proliferative response to
lipopolysaccharide may not be well developed in 1- to
4-week-old gnotobiotic pigs. Therefore, it is difficult to make
any definite comparisons of B-cell proliferation in response
to lipopolysaccharide between these groups.
DISCUSSION
In this report, we provide evidence suggesting that persis-
tent infection by E. coli serotype O111:NM (strain 10049) in
gnotobiotic pigs may be due, at least in part, to the ability of
the organism to compromise the immunoresponsive capacity
of its host. Evidence for immunocompromise was found
both in histologic changes in lymphoidal tissues and in
immune function. These changes included severe depletion
of periarterial lymphatic sheaths in the spleen, loss of
lymphoglandular complexes in the submucosa of the large
intestine, low numbers of lymphocytes in peripheral blood,
lowered proliferative responses to T-cell mitogens, and
decreased antibody production.
Decreased numbers of peripheral lymphocytes may be
accounted for by their migration to lymphoid tissue (5) or
possibly even lymphatic or vascular leakage as seen in
chronic enteric disease (20). Since atrophy of lymphoid
tissue was observed on histologic examination, we could
also suggest that destruction or decreased production of
lymphocytes had occurred. Several studies have indicated
that Shiga toxin (which is essentially identical to VT1) (16) in
cultured human vascular endothelium (28), purified VT1
injected into rabbits (31) and partially purified VT1 injected
into gnotobiotic pigs (7a) can cause vascular damage. Cytol-
ysis of endothelial and other accessory cells would result in
a release of cytokines, which in turn could alter lymphocyte
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number and behavior and account for both the lowered
lymphocyte count and mitogenic responses seen in our study
(6).
We also observed a significantly lower complement-fixing
antibody response to SRBCs in pigs inoculated with VTEC
than in controls. Since T-cell function was compromised in
pigs inoculated with VTEC, as indicated by low mitogenic
responses, the interaction of T-cell cytokines (e.g., interleu-
kin 4, 5, or 6) with B cells may also have been affected and
may have caused a decreased antibody response (32). Pigs
used as bacterial colonization controls (inoculated with
strain G58-1) exhibited an increased capacity to produce
anti-SRBC antibody compared with that of uninoculated
controls. The interaction between the immune system and
the G58-1 organism during the 4 weeks of the experiment
appears to have promoted the development of the humoral
response in these gnotobiotic pigs. This is consistent with
our observations (unpublished observations) that gnotobi-
otic pigs compared with their conventionally raised counter-
parts have slower immunological development and are less
responsive (13).
The mechanism(s) by which strain 10049 compromises the
immune system is not entirely clear. It is tempting to
speculate that verotoxin is a contributing factor since the
O111:NM verotoxin-negative strain 2430 did not persistently
infect gnotobiotic pigs and had a much-less-pronounced
suppressive effect (and, in fact, sometimes had a stimulatory
effect) on immune function than did the verotoxin-positive
strain 10049. Recently, the mechanism by which several
organisms cause chronic or persistent infections has been
attributed to the action of the cytotoxins which they produce
and which are defined as superantigens (14). Some, such as
the staphylococcal enterotoxins, have been shown to sup-
press antibody production in vitro (35) and humoral and
cellular immune responses in vivo (30). Several in vitro
criteria are required to classify a cytotoxin as a superantigen
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FIG. 3. Lymphocyte response to concanavalin A (A), phytohe-
magglutinin (B), and pokeweed mitogen (C). The number of pigs
tested were 13, 6, and 20 (week 1); 13, 6, and 15 (week 2); 11, 4, and
13 (week 3); and 3, 4, and 5 (week 4) for uninoculated pigs (i) and
pigs inoculated with strain 2430 (10) or 10049 ( M ), respectively.
Significant differences (P < 0.05) from results for uninoculated
controls and for pigs inoculated with strain 2430 are indicated by +
and *, respectively.
(3), and studies are in progress to so characterize VT1 (1Sa).
However, since strain 10049 differs from strain 2430 in more
than just the production of verotoxin (strain 10049 is an
EHEC while strain 2430 is an EPEC), additional or other
virulence factors may be responsible for the observed im-
munocompromise.
An 0157:H7, VT1-positive strain (strain 933D) (36) infects
gnotobiotic pigs (10) but does not cause persistent diarrhea
or chronic disease in gnotobiotic pigs (26a). This suggests
that some factor in addition to or other than verotoxin may
contribute to chronic infection. For example, even though
both the EHEC serotypes 0157:H7 and O111:NM attach to
and efface the microvilli of intestinal epithelia in gnotobiotic
pigs, the O111:NM serotype causes more severe intestinal
lesions and is more invasive and necrotizing than the
0157:H7 serotype (26b, 38). Tissue destruction and inva-
siveness by the O111:NM organism might allow greater
access of the verotoxin to lymphatic vessels and the sys-
temic circulation, thereby affecting immune cells. This
greater virulence and invasive capacity may contribute to
the organism's ability to persistently infect its host. In
addition, chronic inflammation seen with strain 10049 could
cause the release of products such as tumor necrosis factor,
while endotoxin levels may also contribute to the immuno-
suppression. Therefore, definitive incrimination of verotoxin
as a contributor to an immunocompromised condition in the
gnotobiotic pig model will require the creation of and chal-
lenge with a verotoxin-negative derivative of strain 10049.
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